National Institute of Allergy and Infectious Diseases

Search
	Advanced Search

Help | Site Index | Contact Us

Radiation Countermeasures
Program
Research Areas
Resources
Funding
Summaries and Publications
Congressional Testimonies
Rocky Mountain Spotted Fever

Medical Countermeasures Against Radiological and Nuclear Threats

Workshop Meeting Summaries and Publications

Medical Countermeasures Against Nuclear Threats: Radionuclide Decorporation Agents, September 17 - 18, 2007 (PDF).

Medical Countermeasures for Radiation Combined Injury: Radiation with Burn, Blast, Trauma and/or Sepsis. Report of an NIAID Workshop, March 26-27, 2007 (PDF).

Centers for Medical Countermeasures Against Radiation (CMCR), 2007 Annual Meeting Report, June 18 – 19, 2007 (PDF).

NIH Strategic Plan and Research Agenda for Medical Countermeasures against Radiological and Nuclear Threats, June 2005 (PDF, 3.39 MB).

Highlights

PA-09-093: Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44]). Standard SBIR receipt dates.

RFA-DK-08-010: Intestinal Stem Cell Consortium (U01) - Co-Funded by the NIAID Radiation/Nuclear Program. Receipt date: March 18, 2009.

Solicitation: BAA-BARDA-09-36 (Due April 17, 2009): Point of Care of High-Throughput Biological Assays for Determining Absorbed Ionizing Radiation Dose (Biodosimetry) after Radiologic and Nuclear Events.

Solicitation: BAA-BARDA-09-34: BARDA Broad Agency Announcement for the Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures

Draft RFP: BAA-BARDA-09-33: Advanced Development of Therapeutics for Treating Neutropenia Resulting from Acute Exposure to Ionizing Radiation.

See Also

Radiological and Nuclear Threats News Releases

Division of Allergy, Immunology, and Transplantation (DAIT)

Biodefense—The NIAID Biodefense Web site includes biodefense-related information for biomedical researchers, the public, and the media.

E-mail this page

Print this page

Plug-ins and Viewers

To open PDFs on this page, download and install the Adobe Acrobat Reader.

Highlights

PA-09-093: Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44]). Standard SBIR receipt dates.

RFA-DK-08-010: Intestinal Stem Cell Consortium (U01) - Co-Funded by the NIAID Radiation/Nuclear Program. Receipt date: March 18, 2009.

Solicitation: BAA-BARDA-09-36 (Due April 17, 2009): Point of Care of High-Throughput Biological Assays for Determining Absorbed Ionizing Radiation Dose (Biodosimetry) after Radiologic and Nuclear Events.

Solicitation: BAA-BARDA-09-34: BARDA Broad Agency Announcement for the Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures

Draft RFP: BAA-BARDA-09-33: Advanced Development of Therapeutics for Treating Neutropenia Resulting from Acute Exposure to Ionizing Radiation.

See Also

Radiological and Nuclear Threats News Releases

Division of Allergy, Immunology, and Transplantation (DAIT)

Biodefense—The NIAID Biodefense Web site includes biodefense-related information for biomedical researchers, the public, and the media.